Al-Here W

Brauer PM

Devine A

Felgentreff K

Gennery AR

Giliani S

Notarangelo LD

Schambach A

Weinacht KG

Zuniga-Pflucker JC

The advent of reprogramming technology has greatly advanced the field of stem cell biology and nurtured our hope to create patient specific renewable stem cell sources. While the number of reports of disease specific induced pluripotent stem cells is continuously rising, the field becomes increasingly more aware that induced pluripotent stem cells are not as similar to embryonic stem cells as initially assumed. Our state of the art understanding of human induced pluripotent stem cells, their capacity, their limitations and their promise as it pertains to the study and treatment of primary immunodeficiencies, is the content of this review

Newcastle University E-Prints

The role of induced pluripotent stem cells in research and therapy of primary immunodeficiencies

The role of induced pluripotent stem cells in research and therapy of primary immunodeficiencies

Abstract

Similar works

Full text

Available Versions

Newcastle University E-Prints